Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1190 | 9278 | 27.5 | 51% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
475 | 3 | RABIES//MEASLES//RABIES VIRUS | 23887 |
1190 | 2 | MEASLES//RUBELLA//IMMUNIZATION | 9278 |
1656 | 1 | IMMUNIZATION//IMMUNIZAT PROGRAM//VACCINE HESITANCY | 2552 |
2103 | 1 | MEASLES//MEASLES VACCINE//MEASLES ELIMINATION | 2357 |
4997 | 1 | RUBELLA//CONGENITAL RUBELLA SYNDROME//RUBELLA VIRUS | 1690 |
11646 | 1 | LOT QUALITY ASSURANCE SAMPLING//IMMUNIZATION COVERAGE//LQAS | 964 |
12144 | 1 | MUMPS//MUMPS VIRUS//MUMPS VACCINE | 928 |
19197 | 1 | NATIONAL IMMUNIZATION TECHNICAL ADVISORY GROUP NITAG//NEW VACCINES//ADVISORY COMMITTEE | 517 |
25847 | 1 | BANDIM HLTH PROJECT//VITAMINS VACCINES CVIVA//NON SPECIFIC EFFECTS OF VACCINES | 270 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MEASLES | authKW | 1296377 | 8% | 54% | 728 |
2 | RUBELLA | authKW | 743036 | 4% | 65% | 349 |
3 | IMMUNIZATION | authKW | 475064 | 9% | 18% | 800 |
4 | MUMPS | authKW | 459173 | 3% | 58% | 239 |
5 | IMMUNIZAT PROGRAM | address | 389540 | 3% | 37% | 318 |
6 | CONGENITAL RUBELLA SYNDROME | authKW | 278788 | 1% | 87% | 97 |
7 | RUBELLA VIRUS | authKW | 247976 | 1% | 71% | 106 |
8 | MEASLES VACCINE | authKW | 242263 | 1% | 60% | 122 |
9 | MUMPS VIRUS | authKW | 217447 | 1% | 72% | 92 |
10 | VACCINE | journal | 179684 | 11% | 6% | 994 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Public, Environmental & Occupational Health | 31202 | 24% | 0% | 2262 |
2 | Immunology | 21117 | 24% | 0% | 2220 |
3 | Infectious Diseases | 20465 | 15% | 1% | 1348 |
4 | Pediatrics | 12173 | 13% | 0% | 1229 |
5 | Virology | 11647 | 9% | 0% | 830 |
6 | Medicine, Research & Experimental | 8363 | 12% | 0% | 1127 |
7 | Medicine, General & Internal | 7420 | 14% | 0% | 1333 |
8 | Microbiology | 3987 | 10% | 0% | 924 |
9 | Tropical Medicine | 3603 | 3% | 0% | 292 |
10 | Health Policy & Services | 2120 | 3% | 0% | 254 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IMMUNIZAT PROGRAM | 389540 | 3% | 37% | 318 |
2 | GLOBAL IMMUNIZAT | 144504 | 1% | 37% | 119 |
3 | BANDIM HLTH PROJECT | 117803 | 1% | 39% | 91 |
4 | IMMUNIZAT VACCINES BIOL | 108984 | 1% | 39% | 86 |
5 | EXPANDED PROGRAMME IMMUNIZAT | 103576 | 1% | 51% | 62 |
6 | IMMUNIZAT P DIS | 88124 | 2% | 12% | 216 |
7 | VITAMINS VACCINES CVIVA | 74637 | 0% | 58% | 39 |
8 | IMMUNIZAT SERV | 65553 | 1% | 24% | 83 |
9 | REFERENCE MEASLES | 42977 | 0% | 93% | 14 |
10 | EXPANDED PROGRAM IMMUNIZAT | 39447 | 0% | 50% | 24 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VACCINE | 179684 | 11% | 6% | 994 |
2 | HUMAN VACCINES & IMMUNOTHERAPEUTICS | 25157 | 1% | 7% | 114 |
3 | EUROSURVEILLANCE | 21862 | 1% | 6% | 105 |
4 | BULLETIN OF THE WORLD HEALTH ORGANIZATION | 21783 | 2% | 4% | 151 |
5 | JOURNAL OF INFECTIOUS DISEASES | 17276 | 3% | 2% | 308 |
6 | EPIDEMIOLOGY AND INFECTION | 15849 | 2% | 3% | 161 |
7 | PEDIATRICS | 13528 | 3% | 2% | 284 |
8 | REVIEWS OF INFECTIOUS DISEASES | 11542 | 1% | 4% | 95 |
9 | AMERICAN JOURNAL OF PREVENTIVE MEDICINE | 11071 | 1% | 3% | 125 |
10 | PEDIATRIC INFECTIOUS DISEASE JOURNAL | 10078 | 2% | 2% | 171 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MEASLES | 1296377 | 8% | 54% | 728 | Search MEASLES | Search MEASLES |
2 | RUBELLA | 743036 | 4% | 65% | 349 | Search RUBELLA | Search RUBELLA |
3 | IMMUNIZATION | 475064 | 9% | 18% | 800 | Search IMMUNIZATION | Search IMMUNIZATION |
4 | MUMPS | 459173 | 3% | 58% | 239 | Search MUMPS | Search MUMPS |
5 | CONGENITAL RUBELLA SYNDROME | 278788 | 1% | 87% | 97 | Search CONGENITAL+RUBELLA+SYNDROME | Search CONGENITAL+RUBELLA+SYNDROME |
6 | RUBELLA VIRUS | 247976 | 1% | 71% | 106 | Search RUBELLA+VIRUS | Search RUBELLA+VIRUS |
7 | MEASLES VACCINE | 242263 | 1% | 60% | 122 | Search MEASLES+VACCINE | Search MEASLES+VACCINE |
8 | MUMPS VIRUS | 217447 | 1% | 72% | 92 | Search MUMPS+VIRUS | Search MUMPS+VIRUS |
9 | VACCINATION | 170056 | 8% | 7% | 700 | Search VACCINATION | Search VACCINATION |
10 | VACCINE HESITANCY | 156823 | 1% | 81% | 59 | Search VACCINE+HESITANCY | Search VACCINE+HESITANCY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | THOMPSON, KM , ODAHOWSKI, CL , (2016) SYSTEMATIC REVIEW OF MEASLES AND RUBELLA SEROLOGY STUDIES.RISK ANALYSIS. VOL. 36. ISSUE 7. P. 1459 -1486 | 278 | 89% | 0 |
2 | THOMPSON, KM , ODAHOWSKI, CL , GOODSON, JL , REEF, SE , PERRY, RT , (2016) SYNTHESIS OF EVIDENCE TO CHARACTERIZE NATIONAL MEASLES AND RUBELLA EXPOSURE AND IMMUNIZATION HISTORIES.RISK ANALYSIS. VOL. 36. ISSUE 7. P. 1427 -1458 | 188 | 93% | 1 |
3 | MCLEAN, HQ , FIEBELKORN, AP , TEMTE, JL , WALLACE, GS , (2013) PREVENTION OF MEASLES, RUBELLA, CONGENITAL RUBELLA SYNDROME, AND MUMPS, 2013 SUMMARY RECOMMENDATIONS OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP).MMWR RECOMMENDATIONS AND REPORTS. VOL. 62. ISSUE 4. P. 1 -34 | 136 | 70% | 76 |
4 | DUBE, E , LABERGE, C , GUAY, M , BRAMADAT, P , ROY, R , BETTINGER, J , (2013) VACCINE HESITANCY AN OVERVIEW.HUMAN VACCINES & IMMUNOTHERAPEUTICS. VOL. 9. ISSUE 8. P. 1763-1773 | 87 | 81% | 47 |
5 | DUBE, E , VIVION, M , MACDONALD, NE , (2015) VACCINE HESITANCY, VACCINE REFUSAL AND THE ANTI-VACCINE MOVEMENT: INFLUENCE, IMPACT AND IMPLICATIONS.EXPERT REVIEW OF VACCINES. VOL. 14. ISSUE 1. P. 99 -117 | 86 | 76% | 15 |
6 | CUTTS, FT , LESSLER, J , METCALF, CJE , (2013) MEASLES ELIMINATION: PROGRESS, CHALLENGES AND IMPLICATIONS FOR RUBELLA CONTROL.EXPERT REVIEW OF VACCINES. VOL. 12. ISSUE 8. P. 917-932 | 87 | 89% | 13 |
7 | HVIID, A , RUBIN, S , MUHLEMANN, K , (2008) MUMPS.LANCET. VOL. 371. ISSUE 9616. P. 932-944 | 82 | 86% | 125 |
8 | THOMPSON, KM , ODAHOWSKI, CL , (2016) SYSTEMATIC REVIEW OF HEALTH ECONOMIC ANALYSES OF MEASLES AND RUBELLA IMMUNIZATION INTERVENTIONS.RISK ANALYSIS. VOL. 36. ISSUE 7. P. 1297 -1314 | 86 | 81% | 0 |
9 | DEMICHELI, V , RIVETTI, A , DEBALINI, MG , DI PIETRANTONJ, C , (2012) VACCINES FOR MEASLES, MUMPS AND RUBELLA IN CHILDREN.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 2. P. - | 103 | 62% | 13 |
10 | DIMECH, W , MULDERS, MN , (2016) A 16-YEAR REVIEW OF SEROPREVALENCE STUDIES ON MEASLES AND RUBELLA.VACCINE. VOL. 34. ISSUE 35. P. 4110 -4118 | 69 | 85% | 0 |
Classes with closest relation at Level 2 |